Sequential neoadjuvant chemotherapy using pegylated liposomal doxorubicin and cyclophosphamide followed by taxanes with complete trastuzumab and pertuzumab treatment for HER2-positive breast cancer: A phase II single-arm study
HER2阳性乳腺癌患者接受序贯新辅助化疗(聚乙二醇化脂质体阿霉素和环磷酰胺)后序贯紫杉烷类药物联合曲妥珠单抗和帕妥珠单抗治疗:一项II期单臂研究
期刊:Chinese Journal of Cancer Research
影响因子:6.3
doi:10.21147/j.issn.1000-9604.2024.01.06
Yang, Yaping; Jin, Liang; Li, Yudong; Rao, Nanyan; Gong, Chang; Li, Shunrong; Wu, Jiannan; Zhao, Jinghua; Ding, Linxiaoxiao; Gan, Fengxia; Zhang, Jun; Feng, Ruifa; Liu, Zhenzhen; Liu, Qiang